• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动优化护理路径的组成部分:来自 COOL-AF 登记研究的整体护理心房颤动患者的赢率分析。

Components of the Atrial fibrillation Better Care pathway for holistic care of patients with atrial fibrillation: a win ratio analysis from the COOL-AF registry.

机构信息

Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2, Wanglang Rd, Bangkok 10700, Thailand.

Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.

出版信息

Europace. 2024 Aug 30;26(9). doi: 10.1093/europace/euae237.

DOI:10.1093/europace/euae237
PMID:39283957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11424996/
Abstract

AIMS

Compliance with integrated care based on the Atrial fibrillation Better Care (ABC) pathway has been associated with improved clinical outcomes. The primary objective of this study was to compare clinical outcomes of AF patients according to the compliant status of each component of the ABC pathway in a hierarchical win ratio approach.

METHODS AND RESULTS

We studied AF patients in the COOL-AF registry. Each patient was followed every 6 months until 3 years. A win ratio analysis was performed, as not all clinical outcomes are equivalent. The hierarchical outcomes were (1) all-cause death, (2) intracranial haemorrhage (ICH), (3) ischaemic stroke/systemic embolism, (4) non-ICH major bleedings, and (5) acute myocardial infarction or heart failure. We also assessed win ratio and win proportion variance over the follow-up time, and the variations over time. A total of 3405 patients (mean age 67.8 ± 11.3; 41.8% female) were studied. Win ratio of ABC-compliant (all three components) vs. ABC-not-compliant was 1.57 (1.35-1.83), P < 0.001. When adding time in therapeutic range (TTR) data for compliant criteria for those who were on warfarin, the win ratio increased to 2.28 (1.89-2.75), P < 0.001. The A-compliant group (plus TTR data), B-compliant, and C-compliant had the win ratio of 1.81 (1.51-2.12), 1.82 (1.53-2.16), and 1.39 (1.18-1.62), all P < 0.001, compared to not compliant group.

CONCLUSION

Management of AF patients according to each component of the ABC pathway is associated with better clinical outcomes compared to those non-compliant to ABC pathway. This finding underscores the importance of a holistic management approach strategy for AF patients.

摘要

目的

基于心房颤动最佳护理(ABC)路径的综合护理依从性与改善临床结局相关。本研究的主要目的是通过分层赢率方法比较 ABC 路径各组成部分依从情况对 AF 患者临床结局的影响。

方法和结果

我们研究了 COOL-AF 登记处的 AF 患者。每位患者每 6 个月随访一次,随访时间长达 3 年。进行了赢率分析,因为并非所有临床结局都是等效的。分层结局为:(1)全因死亡;(2)颅内出血(ICH);(3)缺血性卒中和全身性栓塞;(4)非 ICH 大出血;(5)急性心肌梗死或心力衰竭。我们还评估了随访期间赢率和赢率方差的变化以及随时间的变化。共纳入 3405 例患者(平均年龄 67.8±11.3 岁,41.8%为女性)。ABC 依从组(全部三个组成部分)与 ABC 不依从组的赢率为 1.57(1.35-1.83),P<0.001。对于服用华法林的患者,将符合标准的治疗时间范围(TTR)数据加入 ABC 依从性标准后,赢率增加至 2.28(1.89-2.75),P<0.001。A 组(加 TTR 数据)、B 组和 C 组的赢率分别为 1.81(1.51-2.12)、1.82(1.53-2.16)和 1.39(1.18-1.62),与不依从组相比,均 P<0.001。

结论

与不依从 ABC 路径的患者相比,根据 ABC 路径的每个组成部分管理 AF 患者与更好的临床结局相关。这一发现强调了为 AF 患者实施整体管理策略的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/7308181d59f8/euae237f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/fa9c66ffa1d5/euae237_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/416147c91626/euae237f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/f0a13b22055c/euae237f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/832278b4bd42/euae237f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/6a9faeb4f753/euae237f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/0399341e1f33/euae237f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/6a1e4d74a4f9/euae237f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/7308181d59f8/euae237f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/fa9c66ffa1d5/euae237_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/416147c91626/euae237f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/f0a13b22055c/euae237f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/832278b4bd42/euae237f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/6a9faeb4f753/euae237f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/0399341e1f33/euae237f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/6a1e4d74a4f9/euae237f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3c/11424996/7308181d59f8/euae237f7.jpg

相似文献

1
Components of the Atrial fibrillation Better Care pathway for holistic care of patients with atrial fibrillation: a win ratio analysis from the COOL-AF registry.心房颤动优化护理路径的组成部分:来自 COOL-AF 登记研究的整体护理心房颤动患者的赢率分析。
Europace. 2024 Aug 30;26(9). doi: 10.1093/europace/euae237.
2
Non-vitamin K Antagonist Oral Anticoagulant, Warfarin, and ABC Pathway Adherence on Hierarchical Outcomes: Win Ratio Analysis of the COOL-AF Registry.非维生素 K 拮抗剂口服抗凝药、华法林与 ABC 路径依从性对分层结局的影响:COOL-AF 登记研究的赢率分析。
Thromb Haemost. 2024 Jan;124(1):69-79. doi: 10.1055/s-0043-1772773. Epub 2023 Aug 25.
3
Impact of Achieving Blood Pressure Targets and High Time in Therapeutic Range on Clinical Outcomes in Patients With Atrial Fibrillation Adherent to the Atrial Fibrillation Better Care Pathway: A Report From the COOL-AF Registry.依房颤更好护理路径治疗且血压达标及治疗窗时间达标对房颤患者临床结局的影响:来自 COOL-AF 登记研究的报告。
J Am Heart Assoc. 2023 Feb 7;12(3):e028463. doi: 10.1161/JAHA.122.028463. Epub 2023 Jan 25.
4
Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study.通过遵守简单的 ABC(房颤更好的护理)综合管理路径,提高房颤患者基于人群的临床结局:一项全国性队列研究。
Thromb Haemost. 2019 Oct;119(10):1695-1703. doi: 10.1055/s-0039-1693516. Epub 2019 Jul 2.
5
Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry.基于海湾 SAFE 注册研究,探讨中东地区合并糖尿病的房颤患者 ABC 路径治疗的依从性。
Eur J Clin Invest. 2021 Mar;51(3):e13385. doi: 10.1111/eci.13385. Epub 2020 Sep 13.
6
Relation of changes in ABC pathway compliance status to clinical outcomes in patients with atrial fibrillation: a report from the COOL-AF registry.房颤患者ABC路径依从性状态变化与临床结局的关系:来自COOL-AF注册研究的报告
Eur Heart J Qual Care Clin Outcomes. 2025 May 1;11(3):239-248. doi: 10.1093/ehjqcco/qcae039.
7
Clinical phenotype classification to predict risk and optimize the management of patients with atrial fibrillation using the Atrial Fibrillation Better Care (ABC) pathway: a report from the COOL-AF registry.采用房颤更好管理(ABC)路径对房颤患者进行临床表型分类以预测风险和优化管理:来自 COOL-AF 注册研究的报告。
QJM. 2024 Feb 7;117(1):16-23. doi: 10.1093/qjmed/hcad219.
8
Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.医疗补助计划覆盖的房颤患者的临床特征、口服抗凝模式及转归:来自房颤更明智治疗转归登记研究(ORBIT-AF I)登记处的见解
J Am Heart Assoc. 2016 May 4;5(5):e002721. doi: 10.1161/JAHA.115.002721.
9
Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry.欧洲心房颤动患者结局与 ABC(心房颤动更好护理)路径依从性护理的关系:ESC-EHRA EORP 心房颤动一般长期(AFGen LT)登记处的分析。
Europace. 2021 Feb 5;23(2):174-183. doi: 10.1093/europace/euaa274.
10
Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040.估计 2020 年至 2040 年在英格兰实施房颤综合护理管理方法(Atrial fibrillation Better Care [ABC] 路径)对房颤患者的影响。
Eur Heart J Qual Care Clin Outcomes. 2024 Jun 20;10(4):326-333. doi: 10.1093/ehjqcco/qcad055.

引用本文的文献

1
Polygenic risk-based prediction of heart failure in young patients with atrial fibrillation: an analysis from UK Biobank.基于多基因风险的年轻房颤患者心力衰竭预测:来自英国生物银行的分析。
Europace. 2025 Jul 1;27(7). doi: 10.1093/europace/euaf104.
2
Lifestyle and risk factor modification in atrial fibrillation: a European Heart Rhythm Association survey.心房颤动的生活方式与危险因素修正:一项欧洲心律协会调查
Europace. 2025 Mar 28;27(4). doi: 10.1093/europace/euaf075.
3
Strategies for the prevention of ischemic stroke in atrial fibrillation in East Asia: clinical features, changes and challenges.

本文引用的文献

1
Clinical phenotype classification to predict risk and optimize the management of patients with atrial fibrillation using the Atrial Fibrillation Better Care (ABC) pathway: a report from the COOL-AF registry.采用房颤更好管理(ABC)路径对房颤患者进行临床表型分类以预测风险和优化管理:来自 COOL-AF 注册研究的报告。
QJM. 2024 Feb 7;117(1):16-23. doi: 10.1093/qjmed/hcad219.
2
Non-vitamin K Antagonist Oral Anticoagulant, Warfarin, and ABC Pathway Adherence on Hierarchical Outcomes: Win Ratio Analysis of the COOL-AF Registry.非维生素 K 拮抗剂口服抗凝药、华法林与 ABC 路径依从性对分层结局的影响:COOL-AF 登记研究的赢率分析。
Thromb Haemost. 2024 Jan;124(1):69-79. doi: 10.1055/s-0043-1772773. Epub 2023 Aug 25.
3
东亚地区心房颤动患者缺血性卒中的预防策略:临床特征、变化与挑战
Lancet Reg Health West Pac. 2025 Feb 15;56:101495. doi: 10.1016/j.lanwpc.2025.101495. eCollection 2025 Mar.
4
Integrated Care in Atrial Fibrillation: A Multidisciplinary Approach to Improve Clinical Outcomes and Quality of Life.心房颤动的综合护理:一种改善临床结局和生活质量的多学科方法。
Healthcare (Basel). 2025 Feb 5;13(3):325. doi: 10.3390/healthcare13030325.
5
Global trends and epidemiological impact of metabolic risk factors on atrial fibrillation and atrial flutter from 1990 to 2021.1990年至2021年代谢危险因素对心房颤动和心房扑动的全球趋势及流行病学影响
Sci Rep. 2025 Feb 7;15(1):4561. doi: 10.1038/s41598-025-88744-4.
6
Phenotypes of South Asian patients with atrial fibrillation and holistic integrated care management: cluster analysis of data from KERALA-AF Registry.患有心房颤动的南亚患者的表型及整体综合护理管理:来自喀拉拉邦心房颤动注册研究数据的聚类分析
Lancet Reg Health Southeast Asia. 2024 Nov 14;31:100507. doi: 10.1016/j.lansea.2024.100507. eCollection 2024 Dec.
7
Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation.心房颤动患者中与多种疾病、虚弱和营养不良相关的不良临床结局。
J Nutr Health Aging. 2025 Jan;29(1):100430. doi: 10.1016/j.jnha.2024.100430. Epub 2024 Nov 29.
Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal.
心房颤动与卒中预防:《欧洲心脏杂志》 25 年研究成果
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad226.
4
Integrated Care for Atrial Fibrillation Using the ABC Pathway in the Prospective APHRS-AF Registry.在前瞻性亚太心律学会房颤注册研究中使用ABC路径对房颤进行综合管理
JACC Asia. 2023 Jun 27;3(4):580-591. doi: 10.1016/j.jacasi.2023.04.008. eCollection 2023 Aug.
5
Fallacies of Using the Win Ratio in Cardiovascular Trials: Challenges and Solutions.心血管试验中使用胜率的谬误:挑战与解决方案
JACC Basic Transl Sci. 2023 Jun 26;8(6):720-727. doi: 10.1016/j.jacbts.2023.05.004. eCollection 2023 Jun.
6
Mobile Health-Technology-Integrated Care for Atrial Fibrillation: A Win Ratio Analysis from the mAFA-II Randomized Clinical Trial.移动医疗技术整合房颤治疗:mAFA-II 随机临床试验的赢率分析。
Thromb Haemost. 2023 Nov;123(11):1042-1048. doi: 10.1055/s-0043-1769612. Epub 2023 May 29.
7
Three-year outcomes of patients with non-valvular atrial fibrillation: the COOL-AF registry.非瓣膜性心房颤动患者的三年结局:COOL-AF注册研究
J Geriatr Cardiol. 2023 Mar 28;20(3):163-173. doi: 10.26599/1671-5411.2023.03.008.
8
Causes of death of patients with non-valvular atrial fibrillation in Asians.亚洲人群中非瓣膜性心房颤动患者的死亡原因。
PLoS One. 2023 Mar 1;18(3):e0282455. doi: 10.1371/journal.pone.0282455. eCollection 2023.
9
Predicting Heart Failure in Patients with Atrial Fibrillation: A Report from the Prospective COOL-AF Registry.预测心房颤动患者的心力衰竭:来自前瞻性COOL-AF注册研究的报告。
J Clin Med. 2023 Feb 6;12(4):1265. doi: 10.3390/jcm12041265.
10
Impact of Achieving Blood Pressure Targets and High Time in Therapeutic Range on Clinical Outcomes in Patients With Atrial Fibrillation Adherent to the Atrial Fibrillation Better Care Pathway: A Report From the COOL-AF Registry.依房颤更好护理路径治疗且血压达标及治疗窗时间达标对房颤患者临床结局的影响:来自 COOL-AF 登记研究的报告。
J Am Heart Assoc. 2023 Feb 7;12(3):e028463. doi: 10.1161/JAHA.122.028463. Epub 2023 Jan 25.